A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786

NCT03236233 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus (RSV)

Interventions

DRUG: PC786 - Single doses
DRUG: Placebo - Single doses
DRUG: PC786 - Repeat doses
DRUG: Placebo - Repeat doses

Sponsor

Pulmocide Ltd